Test Price
3,500 AED✅ Home Collection Available
IgVH Hypermutation Analysis Confirmatory Test | 3,500 AED | DNA Labs UAE
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity via ISO-Certified NGS processing. Premium Logistics: Hospital‑Grade, ISO Cold‑Chain Home Collection (8 AM – 11 PM) with VIP Mobile Phlebotomy. Telephonic Post‑Test Clinical Guidance for result interpretation. Direct Billing Verification via WhatsApp at +971 54 548 8731.
Laboratory: DNA Labs UAE – DHA License No. 1143. Turnaround: 10 working days. Method: Next‑Generation Sequencing with derived ratio analysis.
Test Overview & Methodology
The IgVH Hypermutation Analysis Confirmatory Test evaluates somatic hypermutation status of the immunoglobulin heavy chain variable gene using next‑generation sequencing. This molecular assay empowers UAE oncologists and hematologists to make personalized treatment decisions for patients with chronic lymphocytic leukemia (CLL) by delivering definitive prognostic stratification.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% analytical sensitivity & specificity | ~95% sensitivity; may miss low‑level mutations |
| Methodology | NGS + Derived Ratios (ISO 9001:2015) | Sanger sequencing with manual ratio estimation |
| Turnaround Time | 10 working days from receipt | 14 – 21 days typical |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I recognize the critical importance of definitive molecular stratification in CLL. The IgVH hypermutation status directly informs whether a watch‑and‑wait strategy or early intervention is appropriate. This NGS‑based assay provides the highest level of analytical confidence, and our structured post‑test tele‑consultation ensures that every patient and their family fully understands the prognostic implications.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Safety Advisory
Do not discontinue, adjust, or initiate any prescribed therapy solely on the basis of this test result. All treatment decisions must be made by your supervising hematologist or oncologist in the context of a complete clinical evaluation, including imaging and laboratory findings.
Exclusion Criteria & Clinical Red Flags
- Sample hemolysis, clotted specimen, or improper cold‑chain handling
- Recent blood transfusion (within 2 weeks) or concurrent systemic infection
- Known or suspected Richter transformation requiring urgent hematology referral
Seek emergency evaluation if you experience: sudden severe fatigue, unexplained hemorrhage or bruising, fever exceeding 38.3°C, or rapidly progressive lymphadenopathy.
Patient FAQ & Clinical Guidance
1. What does IgVH hypermutation status tell my oncologist about CLL prognosis?
IgVH hypermutation status indicates whether CLL cells have undergone somatic mutations, which strongly correlates with a more indolent disease course, longer treatment‑free survival, and better overall outcome. Mutated IgVH is associated with favorable prognosis, while unmutated IgVH suggests more aggressive disease that may require earlier intervention.
2. Is fasting or any special preparation required before the blood draw?
No fasting or special preparation is required. A simple blood draw in a single lavender‑top EDTA tube, shipped refrigerated without freezing, provides a fully adequate sample for high‑precision NGS analysis. Our VIP mobile phlebotomist will collect the sample at your home between 8 AM and 11 PM under strict ISO cold‑chain protocols.
3. How and when will I receive my IgVH mutation analysis results?
Results are reported within 10 working days from sample receipt, delivered securely through our encrypted patient portal and supplemented with a telephonic consultation by our clinical genetics team to explain every detail and answer any questions you or your family may have.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted end‑to‑end, stored on UAE‑based secure servers, and accessed only by authorized clinical personnel. Clinical laboratory practices adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability to ensure patient safety and consent integrity throughout the testing pathway.
Your sample is processed under ISO 9001:2015 certified workflows with full chain‑of‑custody documentation. No genetic data is shared with third parties without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | IgVH Hypermutation Analysis Confirmatory Test |
| Price (AED) | 3,500 AED |
| Turnaround Time | 10 working days from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (lavender‑top EDTA tube) – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) + Derived Ratio Analysis (ISO 9001:2015) |
| ICD‑10‑CM Code | C91.1 |
| LOINC Code | 81264-9 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians